BIOMAT Database Logo BIOMAT Database Logo

Staphylococcus aureus with reduced susceptibility to glycopeptide antibiotics. 2000

D A Hunstad, and J W St Geme
Washington University, St. Louis, MO, USA.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D006020 Glycopeptides Proteins which contain carbohydrate groups attached covalently to the polypeptide chain. The protein moiety is the predominant group with the carbohydrate making up only a small percentage of the total weight. Glycopeptide
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
D020713 Vancomycin Resistance Nonsusceptibility of bacteria to the action of VANCOMYCIN, an inhibitor of cell wall synthesis.

Related Publications

D A Hunstad, and J W St Geme
Staphylococcus aureus with reduced glycopeptide susceptibility in Liverpool, UK.
April 2010, The Journal of antimicrobial chemotherapy,
D A Hunstad, and J W St Geme
Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
November 2007, International journal of antimicrobial agents,
D A Hunstad, and J W St Geme
Staphylococcus aureus with reduced susceptibility to vancomycin.
August 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
D A Hunstad, and J W St Geme
Staphylococcus aureus with reduced susceptibility to vancomycin.
June 2003, The Ceylon medical journal,
D A Hunstad, and J W St Geme
Emergence, mechanism, and clinical implications of reduced glycopeptide susceptibility in Staphylococcus aureus.
October 2001, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
D A Hunstad, and J W St Geme
[Susceptibility to antibiotics of Staphylococcus aureus strains].
January 1997, Medycyna doswiadczalna i mikrobiologia,
D A Hunstad, and J W St Geme
Reduced susceptibility to vancomycin in Staphylococcus aureus.
November 2011, Emerging infectious diseases,
D A Hunstad, and J W St Geme
Prevalence of isolates with reduced glycopeptide susceptibility in orthopedic device-related infections due to methicillin-resistant Staphylococcus aureus.
December 2012, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
D A Hunstad, and J W St Geme
Staphylococcus aureus with reduced susceptibility to vancomycin--Illinois, 1999.
January 2000, MMWR. Morbidity and mortality weekly report,
D A Hunstad, and J W St Geme
Differential inhibition of Staphylococcus aureus PBP2 by glycopeptide antibiotics.
March 2005, Journal of the American Chemical Society,
Copied contents to your clipboard!